TG and thyroid gland carcinoma: Thyroglobulin (Tg) is a cost-effective and essential biomarker for monitoring differentiated thyroid cancer (DTC) follow-up, especially for low- and intermediate-risk patients with excellent treatment response [11], as per thyroid cancer guidelines [12].